PRKAA2 and colitis: To our knowledge, this study demonstrates for the first time that the inhibition of NOX2 by VAS2870 ameliorates macroscopic and histological scores, MPO levels, reduces colon length, and suppresses the secretion IL-1β, IL-6, and TNF-α independently of AMPK activation in DSS-induced colitis.